Although one study has shown that PD-L1 expression level is high in both recurrent and metastatic oropharyngeal carcinomas (43% and 70%, respectively), there has been no report on changing immunologic profiles according to recurrence in HNSCC30. The gene discussed is CD274; the disease is oropharyngeal carcinoma.